For the first time in the entire history of observations since 2008 in Russia in the first quarter of 2016 fell sales of drugs, according to “Vedomosti” with reference to the report of analysts of DSM Group. The sales decline in the prices of final consumption in January—March 2016 amounted to 10% compared to the same period in 2015. In absolute terms, sales fell from 301 billion to 270 billion rubles for the quarter.
Up to 2016 net sales for the first quarter of the year in terms of value grew steadily: RUB 195 billion (2012), 232 billion RUB (2013), 246 billion rubles (2014).
Physical sales of drugs falling already not the first year. With the exception, as the newspaper notes, was the first quarter of 2015, when consumers were hoarding drugs for future use. For the first three months of this year, the Russians purchased of 1.18 billion packages. Compared to the first quarter of 2015, the drop was 14% (it sold 1.37 billion packs), which also was a record for the first quarter of recent years.
Sales of medications are reduced for the second consecutive quarter since the fourth quarter of 2015, they decreased by 9% in the money and almost 17% in packages. By the end of 2015, the market still increased by 8.2% in rubles and decreased 4.4% of packaging is to maintain the positive dynamics of sales helped results for the first quarter.
Among the main reasons for the decline in demand for drugs, sources said the protracted crisis and decline in purchasing power, as well as the absence in winter of 2016 a large-scale flu epidemic, which has bypassed many parts of the country.
As previously mentioned , in 2015, domestic medicine from the list of vital and essential drugs (EDL) grew in price significantly faster import. This was discussed in the study the HSE on the implementation of the may decrees of the President. The growth of domestic prices for essential drugs in 2015 compared to 2014 was 28.9% — 96 RUB. per pack, prices of imported drugs over the same period was only 4.9% — 364 RUB. for packing, mentioned in the study.
The authors of the study felt that in the segment of the preferential drug holiday, where the average price of the packaging of imported drug in 2015 fell 4.5%, the average domestic price of the drug increased 155.7%.